Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Thousands of New York City nurses are back at work after a strike ended at two of the city's biggest hospitals.
More than a dozen states have now banned substances known as "forever chemicals."
A new study by Columbia University Irving Medical Center said evidence suggests that prolonged sitting has detrimental effects on one's well-being but there is a fix.
Russia is planning a rescue mission to bring home three crewmembers in orbit.
A study says a five-minute light walk can alleviate the effects of sitting at a desk all day.
Swedish mining company LKAB has discovered what CEO Jan Moström called "the largest known deposit of rare earth elements in our part of the world."
Damar Hamlin was released from a Buffalo hospital and will continue to recover at home, just 10 days after the Bills player collapsed on the field and suffered a cardiac arrest.
Crews in California are scrambling to clean up widespread damage as a new storm is expected to hit the northern part of the state.
The Pentagon has dropped Covid-19 vaccine requirements for U.S. troops.
Nurses in New York continue to be on strike for three days as negotiations drag on.
